SCHEDULE: Vivek Ramaswamy Discloses 3.6% Stake in Roivant Sciences

Vivek Ramaswamy has filed an amendment to his Schedule 13G, reporting beneficial ownership of 25,534,970 common shares in Roivant Sciences Ltd.

Summary

• Vivek Ramaswamy reports beneficial ownership of 25,534,970 common shares of Roivant Sciences Ltd.
• The reported stake represents 3.6% of the company's total issued and outstanding common shares.
• The calculation is based on 715,701,137 shares outstanding as of February 2, 2026.
• The filing explicitly excludes 13,357,857 shares held solely by Mr. Ramaswamy's spouse.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral regulatory disclosure reflecting a change in ownership status rather than a fundamental shift in company operations.

Positives

• Transparency regarding significant shareholder positions.
• Clear disclosure of voting and dispositive power held by the reporting person.

Negatives

• The reporting person's stake has fallen below the 5% threshold typically requiring active disclosure, indicating a reduction in influence or position size.

Risks

• Market volatility associated with changes in significant shareholder positions.
• Potential for future divestment or changes in investment strategy by the reporting person.

Future Outlook

The filing does not provide forward-looking guidance or strategic plans regarding the reporting person's investment in the issuer.

Industry Context

StockSavvy.ai notes that Schedule 13G filings by high-profile investors often signal shifts in portfolio allocation or the conclusion of activist positions, which can influence market sentiment regarding the issuer's governance and future direction.

Comparison to Industry Standards

• The filing adheres to standard SEC regulatory requirements for beneficial ownership reporting.
• The disclosure of spousal holdings is consistent with standard transparency practices for individual investors.

Related Party Transactions

• Disclosure of 13,357,857 shares held by the reporting person's spouse.

Stakeholder Impact

• Shareholders may perceive the reduction in stake as a signal of the reporting person's changing outlook on the company.

Next Steps

• Continued monitoring of future SEC filings for potential changes in the reporting person's position.

Key Dates

Keywords

Roivant Sciences, Vivek Ramaswamy, Schedule 13G, Beneficial Ownership, SEC Filing, Common Shares